Patent · US Active

Methods for identification and modification of lncRNA associated with target genotypes and phenotypes

US11591601B2 · kind B2 · utility

0Cited by
97References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 4, 2018
Grant dateFeb 28, 2023
Priority date
Expiry dateMay 4, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The application relates to methods for compositions for identifying lncRNA loci associated with target genotypes or phenotypes, including desirable plant genotypes or phenotype. The application also relates to regulatory regions and genes associated with drug resistance, such as resistance to BRAF-inhibitors. Such regulatory regions and genes form the basis for methods for identifying resistance to BRAF-inhibitors, which is useful for improving disease prognosis, treatment, and likely outcomes. The regulatory regions and genes are also suitable targets for therapy in melanoma that is resistant to BRAF-inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.